Table 2. Subgroup analysis.
Outcomes | Group | RR and 95%CI | P value | Heterogeneity (%) | P value for heterogeneity | Ratios of RR | P value between subgroups |
---|---|---|---|---|---|---|---|
Overall failure | Publication year | ||||||
After 2000 | 2.12 (1.18–3.82) | 0.012 | 3.9 | 0.353 | 0.86 (0.43–1.73) | 0.679 | |
Before 2000 | 2.46 (1.69–3.59) | <0.001 | 0.0 | 0.807 | |||
Country | |||||||
Europe | 2.46 (1.69–3.59) | <0.001 | 0.0 | 0.807 | 1.16 (0.58–2.33) | 0.679 | |
Asia | 2.12 (1.18–3.82) | 0.012 | 3.9 | 0.353 | |||
Sample size | |||||||
100 or more | 2.39 (1.62–3.51) | <0.001 | 0.0 | 0.870 | 1.04 (0.53–2.02) | 0.961 | |
<100 | 2.30 (1.34–3.97) | 0.003 | 0.0 | 0.438 | |||
Mean age | |||||||
40 or more | 1.92 (0.93–3.97) | 0.078 | 0.0 | 0.742 | 0.74 (0.33–1.67) | 0.473 | |
<40 | 2.58 (1.81–3.67) | <0.001 | 0.0 | 0.802 | |||
Percentage male (%) | |||||||
70 or more | 3.14 (1.97–4.98) | <0.001 | 0.0 | 0.927 | 1.62 (0.85–3.07) | 0.140 | |
<70 | 1.94 (1.25–3.01) | 0.003 | 0.0 | 0.821 | |||
Relapse | Publication year | ||||||
After 2000 | 2.45 (1.03–5.83) | 0.044 | 0.0 | 0.432 | 0.86 (0.32–2.33) | 0.770 | |
Before 2000 | 2.84 (1.75–4.61) | <0.001 | 0.0 | 0.975 | |||
Country | |||||||
Europe | 2.84 (1.75–4.61) | <0.001 | 0.0 | 0.975 | 1.16 (0.43–3.13) | 0.770 | |
Asia | 2.45 (1.03–5.83) | 0.044 | 0.0 | 0.432 | |||
Sample size | |||||||
100 or more | 2.89 (1.61–5.21) | <0.001 | 0.0 | 0.926 | 1.12 (0.48–2.60) | 0.798 | |
<100 | 2.59 (1.41–4.76) | 0.002 | 0.0 | 0.807 | |||
Mean age | |||||||
40 or more | 3.15 (1.07–9.31) | 0.038 | 0.0 | 0.596 | 1.18 (0.36–3.83) | 0.783 | |
<40 | 2.67 (1.68–4.25) | <0.001 | 0.0 | 0.909 | |||
Percentage male (%) | |||||||
70 or more | 3.16 (1.79–5.60) | <0.001 | 0.0 | 0.906 | 1.39 (0.59–3.27) | 0.457 | |
<70 | 2.28 (1.20–4.34) | 0.012 | 0.0 | 0.797 |